Skip to content
Recall Observatory FDA recall evidence

Drug product

IRINOTECAN HYDROCHLORIDE INJECTION, 40 mg/2 mL (20 mg/mL), 2 mL Single Dose Vial, Rx only, Manufactured for: APP Pharmaceuticals, LLC, Schaumburg, IL 60173, NDC 63323-193-02, UPC 3 63323 19302 7.

D-915-2013

January 22, 2013

Class II

Product summary

Firm
Fresenius Kabi USA LLC (FK USA)
Event
Event 64102
Status
Terminated
Classification
Class II
Quantity
23,672 vials
Official record key
drug-enforcement:D-915-2013

Official wording

Reason: Crystallization: Active pharmaceutical ingredient is precipitating in product solution.

Code information: Lot #: 872CZ00101, Exp 12/13

Distribution pattern: Nationwide

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Crystallization: Active pharmaceutical ingredient is precipitating in product solution.